← Back to Search

Visual Feedback Gait Training for Stroke

Q: What are the qualifications for participation in this clinical experiment?

To participate in this clinical trial, individuals should have had a <a href="https://www.withpower.com/clinical-trials/stroke">stroke</a> and be between the ages of 20 and 80. The researchers are looking for approximately 50 enrollees.

Q: How many participants are partaking in the current clinical experiment?

Affirmative. According to clinicaltrials.gov, this medical trial is actively enrolling patients with the post date starting on February 6th 2019 and last updated on March 2nd 2022. The research team seeks out 50 participants from a single location.

Q: Is there an age limit for participation in this research trial?

This clinical trial invites participants aged between 20 and 80 years old to join.

Q: Are there any available openings for participants in this experiment?

The clinical trial page on clinicaltrials.gov affirms that this study is actively recruiting patients; the protocol was first published in February 6th 2019 and last edited on March 2nd 2022.

N/A

Recruiting

Led By Amy J Bastian, PhD, PT

Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults age 20-80

Patients able to walk for 5 minutes at their self-paced speed

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.

Awards & highlights

Study Summary

This trial will test whether different forms of visual feedback can help people with stroke modify their gait pattern.

Who is the study for?

This trial is for adults aged 20-80 who have had a stroke or hemiparesis at least 6 months ago. Participants should be able to walk, even if they need a cane or walker, and must manage a 5-minute walk at their own pace. It's not suitable for those with certain neurological conditions other than stroke, severe communication difficulties due to aphasia, uncontrolled heart issues, diabetes, cognitive impairment (MoCA score <23), pregnancy, or walking limitations from orthopedic conditions.Check my eligibility

What is being tested?

The study tests how gait training with visual feedback on leg movements can help people who've had a stroke improve their walking patterns over time. The goal is to see if seeing one's own joint movements while walking helps retrain the brain and muscles to normalize the way participants walk.See study design

What are the potential side effects?

Since this intervention involves physical therapy techniques rather than medication, side effects may include muscle soreness or fatigue related to exercise. There might also be some frustration or psychological stress associated with learning new movement patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 20 and 80 years old.

Select...

I can walk for 5 minutes at my own pace.

Select...

I had a stroke or weakness on one side of my body more than 6 months ago.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

1. Change in hip and knee joint movements while walking

Secondary outcome measures

1. Change in walking speed

2. Change in subjective assessment of balance confidence

Trial Design

2Treatment groups

Experimental Treatment

Group I: Single Channel Visual FeedbackExperimental Treatment1 Intervention

Gait training with visual feedback of joint kinematics. The visual feedback will contain information about the lower limb joint angles. We will instruct subjects to use the feedback to reach a target walking pattern. In this arm, subjects will receive 1 channel of visual information that encompasses information from 4 lower limb joint angles (right and left hips, right and left knees).

Group II: Multichannel Visual FeedbackExperimental Treatment1 Intervention

Gait training with visual feedback of joint kinematics. The visual feedback will contain information about the lower limb joint angles. We will instruct subjects to use the feedback to reach a target walking pattern. In this arm, subjects will receive 4 channels of visual information, each of which represents a joint angle (right and left hips, right and left knees).

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor

88 Previous Clinical Trials

24,888 Total Patients Enrolled

2 Trials studying Stroke

126 Patients Enrolled for Stroke

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,538 Total Patients Enrolled

38 Trials studying Stroke

7,750 Patients Enrolled for Stroke

National Institute of Neurological Disorders and Stroke (NINDS)NIH

1,339 Previous Clinical Trials

649,340 Total Patients Enrolled

171 Trials studying Stroke

83,808 Patients Enrolled for Stroke

Media Library

Gait training with visual feedback of joint kinematics Clinical Trial Eligibility Overview. Trial Name: NCT03813342 — N/A

Stroke Research Study Groups: Single Channel Visual Feedback, Multichannel Visual Feedback

Stroke Clinical Trial 2023: Gait training with visual feedback of joint kinematics Highlights & Side Effects. Trial Name: NCT03813342 — N/A

Gait training with visual feedback of joint kinematics 2023 Treatment Timeline for Medical Study. Trial Name: NCT03813342 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the qualifications for participation in this clinical experiment?

"To participate in this clinical trial, individuals should have had a stroke and be between the ages of 20 and 80. The researchers are looking for approximately 50 enrollees."

Answered by AI

How many participants are partaking in the current clinical experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is actively enrolling patients with the post date starting on February 6th 2019 and last updated on March 2nd 2022. The research team seeks out 50 participants from a single location."

Answered by AI

Is there an age limit for participation in this research trial?

"This clinical trial invites participants aged between 20 and 80 years old to join."

Answered by AI

Are there any available openings for participants in this experiment?

"The clinical trial page on clinicaltrials.gov affirms that this study is actively recruiting patients; the protocol was first published in February 6th 2019 and last edited on March 2nd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Retraining the Walking Pattern After Stroke

Amy J. Bastian, Ph.D. 2019. "Retraining the Walking Pattern After Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03813342.

All > Stroke